日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Metabolic Dysfunction-Associated Steatotic Liver Disease After Hepatitis C Virus Cure

丙型肝炎病毒治愈后代谢功能障碍相关性脂肪肝疾病

Huang, Chung-Feng; Huang, Jee-Fu; Yu, Ming-Lung; Chuang, Wan-Long

The Proteomic Profiling of Circulating Extracellular Vesicles of Western Diet and Chemical-Induced Murine MASH Model

西方饮食和化学诱导的小鼠MASH模型循环细胞外囊泡的蛋白质组学分析

Wang, Szu-Jen; Wang, Yung-Ho; Huang, Jee-Fu; Lin, En-Sheng; Chen, Wei-Shiun; Li, Chia-Yang; Dai, Chia-Yen; Chuang, Wan-Long; Yu, Ming-Lung; Wang, Shu-Chi

Steatotic liver disease in chronic hepatitis C related hepatocellular carcinoma: Inflictor or bystander?: Correspondence to editorial on "Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan"

慢性丙型肝炎相关肝细胞癌中的脂肪肝:是罪魁祸首还是旁观者?:对“慢性丙型肝炎患者病毒清除后代谢功能障碍相关脂肪肝的动态变化:台湾全国登记研究”一文的社论的回应

Huang, Chung-Feng; Yeh, Ming-Lun; Dai, Chia-Yen; Huang, Jee-Fu; Chuang, Wan-Long; Yu, Ming-Lung

Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues

代谢综合征疾病对接受核苷(酸)类似物治疗的慢性乙型肝炎患者长期预后的影响

Huang, Rui; Jun, Dae Won; Toyoda, Hidenori; Hsu, Yao-Chun; Trinh, Huy; Nozaki, Akito; Ishikawa, Toru; Watanabe, Tsunamasa; Uojima, Haruki; Huang, Daniel Q; Honda, Takashi; Tanaka, Yasuhito; Vutien, Philip; Marciano, Sebastián; Abe, Hiroshi; Enomoto, Masaru; Atsukawa, Masanori; Takahashi, Hirokazu; Tsuji, Kunihiko; Takaguchi, Koichi; Tsai, Pei-Chien; Dai, Chia-Yen; Huang, Jee-Fu; Huang, Chung-Feng; Yeh, Ming-Lun; Yoon, Eileen; Kim, Sung Eun; Ahn, Sang Bong; Kim, Gi-Ae; Jung, Jang Han; Jeong, Soung Won; Oh, Hyunwoo; Tseng, Cheng-Hao; Ishigami, Masatoshi; Chau, Angela; Maeda, Mayumi; Yasuda, Satoshi; Chuma, Makoto; Ito, Takanori; Kawashima, Keigo; Liu, Joanne Kimiko; Gadano, Adrian; Kozuka, Ritsuzo; Itokawa, Norio; Inoue, Kaori; Senoh, Tomonori; Li, Jie; Chuang, Wan-Long; Cheung, Ramsey; Wu, Chao; Yu, Ming-Lung; Nguyen, Mindie H

Impact of metabolic dysfunction on treatment responses to nucleos(t)ide analogues in chronic hepatitis B: a retrospective multi-center REAL-B cohort study

代谢功能障碍对慢性乙型肝炎患者核苷(酸)类似物治疗反应的影响:一项回顾性多中心 REAL-B 队列研究

Huang, Rui; Jun, Dae Won; Toyoda, Hidenori; Hsu, Yao-Chun; Trinh, Huy; Nozaki, Akito; Ishikawa, Toru; Watanabe, Tsunamasa; Uojima, Haruki; Huang, Daniel Q; Honda, Takashi; Tanaka, Yasuhito; Vutien, Philip; Marciano, Sebastián; Abe, Hiroshi; Enomoto, Masaru; Atsukawa, Masanori; Takahashi, Hirokazu; Tsuji, Kunihiko; Itobayashi, Ei; Takaguchi, Koichi; Tsai, Pei-Chien; Dai, Chia-Yen; Huang, Jee-Fu; Huang, Chung-Feng; Yeh, Ming-Lun; Yoon, Eileen; Kim, Sung Eun; Ahn, Sang Bong; Kim, Gi-Ae; Jung, Jang Han; Jeong, Soung Won; Oh, Hyunwoo; Tseng, Cheng-Hao; Ishigami, Masatoshi; Chau, Angela; Hsiao, Tiffany; Maeda, Mayumi; Yasuda, Satoshi; Chuma, Makoto; Ito, Takanori; Kawashima, Keigo; Liu, Joanne Kimiko; Gadano, Adrian; Kozuka, Ritsuzo; Itokawa, Norio; Inoue, Kaori; Senoh, Tomonori; Li, Jie; Chuang, Wan-Long; Cheung, Ramsey; Wu, Chao; Yu, Ming-Lung; Nguyen, Mindie H

Corrigendum to "The Role of Mitochondrial AKT1 Signaling in Renal Tubular Injury of Metabolic Syndrome" [Kidney International Reports Volume 10, Issue 3, March 2025, Pages 906-920]

对“线粒体 AKT1 信号在代谢综合征肾小管损伤中的作用”的更正[肾脏国际报告第 10 卷,第 3 期,2025 年 3 月,第 906-920 页]

Lin, Hugo Y-H; Chen, I-Ya; Wang, Tzu-Ming; Yen, Chia-Hung; Chen, Yumay; Chen, Yen-Hua; Dai, Dao-Fu; Huang, Jee-Fu; Chiu, Yi-Wen; Yang, Ming-Yu; Lin, Chang-Shen

The Role of Mitochondrial AKT1 Signaling in Renal Tubular Injury of Metabolic Syndrome.

线粒体AKT1信号在代谢综合征肾小管损伤中的作用

Lin Hugo Y-H, Chen I-Ya, Wang Tzu-Ming, Yen Chia-Hung, Chen Yumay, Chen Yen-Hua, Dai Dao-Fu, Huang Jee-Fu, Chiu Yi-Wen, Yang Ming-Yu

Long-Term Hepatic and Extrahepatic Outcomes of Chronic Hepatitis C Patients After Sofosbuvir-Based Treatment (LONGHEAD Study)

索非布韦治疗慢性丙型肝炎患者的长期肝脏和肝外结局(LONGHEAD 研究)

Huang, Chung-Feng; Heo, Jeong; Chien, Rong-Nan; Baek, Yang-Hyun; Kao, Jia-Horng; Kim, Ju-Hyun; Chang, Ting-Tsung; Byun, Kwan-Soo; Chen, Jyh-Jou; Jeong, Sook-Hyang; Hu, Tsung-Hui; Kim, Young-Seok; Peng, Cheng-Yuan; Tak, Won-Young; Wang, Horng-Yuan; Yoon, Seung-Kew; Sheen, I-Shyan; Youn-Jae Lee; Hsu, Yu-Chun; Yim, Hyung-Joon; Tsai, Pei-Chien; Yeh, Ming-Lun; Ahn, Sang-Hoon; Dai, Chia-Yen; Paik, Seung-Woon; Huang, Jee-Fu; Kim, Yoon-Jun; Chuang, Wan-Long; Lim, Young-Suk; Yu, Ming-Lung

Association of CD33 genetic variants with neurocognitive profiles in chronic viral hepatitis

CD33基因变异与慢性病毒性肝炎患者神经认知特征的关联

Tsai, Wei-Fang; Yu, Rwei-Ling; Chuang, Wan-Long; Huang, Jee-Fu; Dai, Chia-Yen; Huang, Yu-Wen Alvin; Tan, Chun-Hsiang

Real-world efficacy and safety of universal 8-week glecaprevir/pibrentasvir in patients with chronic hepatitis C with early chronic kidney disease or pre-end-stage renal disease: Insights from a nationwide hepatisis C virus registry in Taiwan

台湾全国丙型肝炎病毒登记研究揭示了在合并早期慢性肾病或终末期肾病前期慢性丙型肝炎患者中,普遍采用8周格卡瑞韦/哌仑他韦治疗的真实世界疗效和安全性:

Wang, Szu-Jen; Huang, Chung-Feng; Chang, Te-Sheng; Lo, Ching-Chu; Hung, Chao-Hung; Huang, Chien-Wei; Chong, Lee-Won; Cheng, Pin-Nan; Yeh, Ming-Lun; Peng, Cheng-Yuan; Cheng, Chien-Yu; Huang, Jee-Fu; Bair, Ming-Jong; Lin, Chih-Lang; Yang, Chi-Chieh; Kuo, Hsing-Tao; Hsieh, Tsai-Yuan; Lee, Tzong-Hsi; Lee, Pei-Lun; Wu, Wen-Chih; Lin, Chih-Lin; Su, Wei-Wen; Yang, Sheng-Shun; Wang, Chia-Chi; Hu, Jui-Ting; Mo, Lein-Ray; Chen, Chun-Ting; Huang, Yi-Hsiang; Chang, Chun-Chao; Huang, Chia-Sheng; Chen, Guei-Ying; Kao, Chien-Neng; Tai, Chi-Ming; Liu, Chun-Jen; Lee, Mei-Hsuan; Tsai, Pei-Chien; Dai, Chia-Yen; Kao, Jia-Horng; Lin, Han-Chieh; Chuang, Wang-Long; Tseng, Kuo-Chih; Chen, Chi-Yi; Wang, Shu-Chi; Yu, Ming-Lung